MARÍA JOSÉ
SERRANO FERNÁNDEZ
Researcher in the period 2022-2023
Universidad de Jaén
Jaén, EspañaPublications in collaboration with researchers from Universidad de Jaén (10)
2018
-
Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
Journal of Translational Medicine, Vol. 16, Núm. 1
2017
-
A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs
Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482
-
Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers
European Journal of Cardio-thoracic Surgery, Vol. 52, Núm. 1, pp. 55-62
2016
-
Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection
PLoS ONE, Vol. 11, Núm. 2
-
Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC)
Surgery (United States), Vol. 159, Núm. 3, pp. 728-735
2014
-
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497
2013
-
CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407
2012
-
Biomarkers characterization of circulating tumour cells in breast cancer patients
Breast Cancer Research, Vol. 14, Núm. 3
-
Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy
Experimental and Therapeutic Medicine, Vol. 4, Núm. 1, pp. 43-48
2011
-
Circulating tumour cells in peripheral blood: Potential impact on breast cancer outcome
Clinical and Translational Oncology, Vol. 13, Núm. 3, pp. 204-208